KFSHRC advances robotic surgery with a successful Ivor Lewis Esophagectomy
The procedure was led by Dr. Khalid Aldaghri, Consultant in bariatric, upper gastrointestinal, and robotic surgery at KFSHRC. Utilizing the Ivor Lewis technique, a complex and technically demanding procedure involving two phases. The abdominal phase involved stomach mobilization and creation of a gastric conduit. This was followed by the thoracic phase, in which the diseased esophagus was resected and the conduit is robotically connected within the chest.
Precision in the robotic system enabled surgeons to reach deep anatomical areas without large incisions, enhancing safety, reducing risks, and improving outcomes in one of the most complex cancer surgeries.
Close collaboration among surgical, anesthesia, nursing, and technical teams was key to the procedure's success. All teams worked synchronously across every stage, from pre-op planning to post-op recovery. This approach reflects KFSHRC's multidisciplinary model of care, designed to improve patient outcomes and boost clinical efficiency.
With its advanced features, the robotic surgery significantly enhanced the safety and accuracy of the esophagectomy by offering three-dimensional high-definition visualization, stable instrument control, and superior access within confined anatomical spaces. These capabilities enabled more precise dissection, better preservation of surrounding structures such as nerves and vessels and reduced intraoperative risks. The technology also made it physically easier for the surgeon to operate over an extended period.
As a medical milestone, the success of this procedure opens the door for broader applications of robotic surgery at KFSHRC. It enables more patients to benefit from advanced surgical techniques and reinforces the institution's commitment to clinical innovation, safety, and effective alternatives to traditional surgical approaches.
It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for 2025. It was also recognized as the most valuable healthcare brand in the Kingdom and the Middle East by Brand Finance in 2024 and was listed among the World's Best Smart Hospitals by Newsweek for 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
10 hours ago
- Zawya
Saudi: Fakeeh group delivers H1 2025 revenue of $402.4mln, up 13% year-on-year
Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: 'In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities —investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah—developed in partnership with Yasser Yousef Naghi Investment Company—a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem—with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum—continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
13 hours ago
- Zawya
Three-Day Longevity & Wellness Summit set to transform health innovation landscape in Saudi Arabia
RIYADH, Saudi Arabia /PRNewswire/ -- Zenos Health, the premium wellness and longevity company founded by brothers Mazen and Marwan Karnaby, today announced the first inaugural Zenos Wellness Summit, taking place October 23-25, 2025, at the iconic Bab Samhan Hotel in Riyadh, Saudi Arabia. The groundbreaking three-day summit represents the Middle East's first comprehensive gathering focused on longevity science, biohacking, and integrative medicine, bringing together global pioneers, researchers, and wellness experts under Saudi Arabia's Vision 2030 health innovation initiative. The summit will feature an impressive roster of international health and longevity experts, including: Dr. Mark Hyman – Functional Medicine Physician Gary Brecka – Human Biologist & Longevity Expert Dr. Amy Shah – Specializing in Gut-Brain Science Dr. Sara Al Madani – Award-Winning Serial Entrepreneur & Wellness Expert Tim Gray – Europe's Leading Biohacker Courtney Swan, MS – Integrative Nutritionist Cynthia Thurlow, NP – Hormonal Health Specialist Dr. Vonda Wright – Orthopedic Surgeon & Aging Expert Dr. Leigh Erin Connealy – Integrative Oncology Pioneer Dr. Angie Kassabie – Elite Nutritionist Dr. Shawana Vali – Cosmetic Dermatologist Dr. Carrie Jones – A Naturopathic Physician, Board-certified in Endocrinology Mary Christine – Longevity Nutritionist Additional speakers from the United States, United Kingdom, and Middle East will explore cutting-edge topics including biohacking and longevity, functional and precision medicine, nutritional science, AI-powered diagnostics, and emotional well-being optimization. In addition to traditional conference programming, each evening will transform into immersive cultural and entertainment experiences set against Saudi Arabia's stunning desert landscape, featuring themed nights that blend local Saudi culture, international artistry, and cutting-edge performances in a vibrant supper-club atmosphere. "The future belongs to those who lead their evolution – mind, body, and performance," said Mazen and Marwan Karnaby, founders of Zenos Health. "Longevity isn't a trend, it's a responsibility. Zenos Health Summit is where those who are serious about changing the game come to rise." Three access levels are available to accommodate different audiences: Diamond Pass ($5,997 USD) - Premier all-access VIP experience with full speaker sessions, premium hospitality, priority seating, wellness programming access, VIP hotel rates, and dedicated concierge service Platinum Pass ($3,500 USD) - Daytime-only access including keynote speakers, panels, breakout sessions, and exhibitor hall Golden Pass ($3,500 USD) - Evening-focused experience for cultural enthusiasts featuring signature programming, wellness workshops, and premium hospitality About Zenos Health Founded by brothers Mazen and Marwan Karnaby, Zenos Health stands at the forefront of the wellness industry, delivering premium, science-backed supplements meticulously formulated in advanced, registered facilities in the United States. The company's mission is to empower individuals to take control of their health and unlock their fullest potential through clean, innovative, and highly effective solutions for optimal living.
Economy ME
15 hours ago
- Economy ME
WHX Dubai, WHX Labs to gather 270,000 leaders from 180 nations to tackle global healthcare challenges
Informa has unveiled the launch of the world's largest healthcare event, following the decision to host two flagship gatherings simultaneously in 2026. From February 9 to 13, 2026, WHX Dubai (formerly known as Arab Health) and WHX Labs Dubai (previously Medlab Middle East) will convene over 270,000 healthcare leaders from 180 nations and more than 4,800 exhibitors, transforming Dubai into a global healthcare hub and a catalyst for medical advancement. For decades, these events have positioned Dubai at the core of global healthcare conversations. Set to occur concurrently in 2026, under the auspices of the UAE Ministry of Health and Prevention, they will merge to create the world's largest healthcare event—a city-wide opportunity for deal-making, networking, and knowledge-sharing that addresses universal healthcare and laboratory challenges. WHX Dubai will take place from February 9 to 12 at the Dubai Exhibition Centre (DEC) in Expo City Dubai, marking a historic milestone as the event will be held outside the Dubai World Trade Centre (DWTC) for the first time in its 50-year history. Record-breaking business value The exhibition will draw an international audience and serve as a global platform for innovation, allowing exhibitors to present solutions across nine diverse product sectors, including medical devices, imaging and diagnostics, and healthcare infrastructure. The 50th edition of this event, which occurred earlier this year, generated a record-breaking $2.57 billion in business value, with each exhibitor experiencing an average impact of $2.14 million. WHX Dubai 2026 is poised to enhance global health with a forward-thinking program that includes seven CME-accredited conferences and over 250 speakers. This edition will introduce four new certified boot camps and three dedicated stages: the Future X Stage for pioneering ideas; the Frontiers Stage, showcasing the latest advancements in science, wellness, and life sciences; and the Visionary Stage, where global leaders will offer insightful perspectives on investment, leadership, artificial intelligence, and ESG. As it marks its 25th anniversary in 2026, WHX Labs Dubai will occur from February 10 to 13 at DWTC. Under the theme '25 Years of Laboratory Innovation: Uniting Communities for Better Health,' the event will highlight excellence in laboratories, diagnostics, and precision medicine. Last year, WHX Labs Dubai generated $621 million in business, serving as a platform that connected key buyers, government ministries, and decision-makers driving diagnostics-related innovation and investment in the Middle East. Accelerating global healthcare solutions WHX Labs Dubai will showcase the latest advancements from across the medical lab ecosystem through eight product pillars. Additionally, the 25th Annual Laboratory Management and Medicine Congress will feature eight CME-accredited scientific conference tracks with 250 global thought leaders and laboratory specialists. Attendees can engage in industry-defining discussions at the WHX Labs Roundtables and partake in two new clinician conferences: the Precision Health Global Forum and the Antimicrobial Resistance Leadership Global Summit. Solenne Singer, senior vice president at Informa Markets, stated: 'WHX Dubai and WHX Labs Dubai are both well-established events with a proven track record of advancing knowledge and trade at both regional and global levels. We are delighted to host them concurrently to form the world's largest healthcare event, which will transform Dubai into a hub for the global healthcare ecosystem for five enlightening days. 'Dubai's unique position will enable bold ideas and breakthroughs to cross borders rapidly, accelerating the spread of solutions from one market to another while reinforcing the UAE's status as an international center for healthcare transformation. By hosting the world's largest healthcare event, our attendees will make a significant contribution to future advances in medical excellence and innovation in the UAE and beyond.'
